SynCardia Gets More Payment For Artificial Heart, Seeks To Grow Market
This article was originally published in The Gray Sheet
Executive Summary
Having recently gained improved reimbursement for its CardioWest artificial heart, SynCardia Systems says its plans to make the device more portable could quadruple sales within two years of a U.S. introduction
You may also be interested in...
CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter
Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO
CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter
Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO
Lung Valve Device Wins Medicare Inpatient Add-On Payment
The Spiration IBV Valve System is the only product to gain a new technology add-on payment from CMS under the 2010 inpatient prospective payment system rule released July 31